• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Aug27
CICC Raises Target Price for Ocuvita Biotech to HKD 10.16
03:15
Aug25
Ocumetrix Biotech Sees Significant Revenue Growth in 2025 H1
02:32
Aug21
OCUMENSION-B released FY2025 Q1 earnings on August 21, 2025 (BJT) with actual revenue of HKD 157.45 M and EPS of HKD -0.0897
15:00
Oculeve's OT-301 drug reaches primary endpoint in Phase III clinical trial
11:52
OCUMENSION-B released FY2025 Q2 earnings on August 21 During-Market (BJT), actual revenue HKD 160.91 M, actual EPS HKD -0.0917
08:00
OCUMENSION-B released FY2025 Semi-Annual Earnings on August 21 During-Market (BJT), actual revenue HKD 318.36 M (forecast HKD 347.7 M), actual EPS HKD -0.1815 (forecast HKD -0.1313)
08:00

Schedules & Filings

Schedules
Filings
Aug21
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 160.91 M, Net Income -72.41 M, EPS -0.0917

Mar31
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 132.81 M, Net Income -62.2 M, EPS -0.0878

Aug12
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 90.06 M, Net Income -81.31 M, EPS -0.1235

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08413
0.208
+80.87%
+0.093
08186
0.780
+64.21%
+0.305
01239
0.500
+58.73%
+0.185
08311
0.090
+57.89%
+0.033
01790
0.570
+52.00%
+0.195
00924
0.140
+29.63%
+0.032
08360
0.325
+27.45%
+0.070
00209
0.182
+22.97%
+0.034
08331
0.260
+19.82%
+0.043
08357
0.097
+19.75%
+0.016
View More